CME

Vanderbilt Urology Society
2026 VUS Annual Meeting
October 19 – 20, 2026
Nashville, TN

Continuing Education Language

Acknowledgement of Financial Commercial Support

No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support

No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Vanderbilt Urology Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco Joint Accreditation Provider Number: 4008163

Professions in scope for this activity are listed below.

Physicians

Amedco LLC designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Physician Assistants

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification for PAs.

 Amedco LLC designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. PAs should claim only the credit commensurate with the extent of their participation in the activity.

Objectives – After Attending This Program You Should Be Able To

  1. Discuss optimal management for renal cell
  2. Discuss quality of life outcomes in women and men after cancer
  3. Review and rethink NMIBC

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been mitigated in accordance with S3: 1-5, JAC 12c.

All individuals in a position to control the content of CE are listed below.

Name Commercial Interest:Relationship
Mohammad Allaf NA
Caleb Ashbrook NA
Daniel Barocas NA
Taylor Brewer NA
Jackson Cabo NA
sam chang Ferring, enGene, Merck, ImmunityBio, Urogen, Pacific edge, Pfizer, Photocure, Johnson and Johnson, Vesica health:Consultant
Meredith Donahue NA
Brendan Frainey NA
Sara Francescon NA
Veerain Gupta NA
Alexandra Jacobs NA
Gautam Jayram Merck, Tempus, Pfizer, AstraZeneca:Scientific/Medical Advisory Board Member; Photocure, KDx Diagnostics, Cardinal Health, Janssen, ImmunityBio:Consultant; Ferring:Speakers Bureau
Niels Johnsen Boston Scientific:Consultant
Shreyas Joshi Ferring, UroGen:Scientific/Medical Advisory Board Member
Daniel Joyce Carepath, Telix, Ferring:Consultant
Melissa Kaufman Boston Scientific, Cook Myosite:Research Grant Overall Principal Investigator; Medtronic:Research Grant Site Principal Investigator; Levee Medical, Augment Medical, Laborie:Scientific/Medical Advisory Board Member
nicholas kavoussi NA
Amy Luckenbaugh NA
Nicole Miller Boston Scientific, Ventaris Surgical, Ambu:Consultant; Karl Storz Endoscopy:Speakers Bureau; Novo Nordisk, Akeeko Medical:Scientific/Medical Advisory Board Member
Charan Mohan NA
Kelvin Moses Boston Scientific:Other
Wendy Nichols NA
Maggie O’Block NA
david penson NA
Brian Rini Merck, BMS, Pfizer, Exelixis:Consultant
Jennifer Robles Boston Scientific:Other
Kristen Scarpato UroGen:Scientific/Medical Advisory Board Member; cxbladder:Research Grant Site Principal Investigator; photocure:Speakers Bureau
Kerry Schaffer Novartis:Consultant
Elisabeth Sebesta NA
Tara Sweeney NA
Jeff Tosoian LynxDx:Consultant
Elizabeth Winkler NA
Tracy Peterson NA